Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NSPR Feb 2023 5.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 01:32PM EDT. Market open.
Advertisement
Full screen
Previous Close0.0500
Open0.0500
Bid0.0000
Ask0.3500
Strike5.00
Expire Date2023-02-17
Day's Range0.0500 - 0.0500
Contract RangeN/A
Volume1
Open Interest7
  • GlobeNewswire

    InspireMD Announces Presentation at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) Conference

    TEL AVIV, Israel, Sept. 13, 2022 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke, today announced that the company will deliver a presentation at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) Conference, which is being held September 16-19, 2022, at the Boston Convention and Exhibition Center in Boston, MA. Details of the presentation are as follows: Title:Endovascular Sequestration of High-Risk

  • Business Wire

    NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development

    TOLEDO, Ohio & TEL AVIV, Israel, September 08, 2022--NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for treatment of carotid artery disease and prevention of stroke, announced today that they have entered into a strategic outsourcing partnership to accelerate medical device development and commercialization.

  • GlobeNewswire

    InspireMD Reports Second Quarter 2022 Financial Results and Provides Business Update

    - Generated 47.8% growth in CGuard™ revenue year-over-year - - Delivered several presentations at LINC 2022 featuring CGuard™ EPS, including a successful live case transmission - - Announced that endovascular pioneer Dr. Juan Parodi has agreed to act as strategic advisor to the company - --Management to Host Investor Conference Call Today, August 9th, at 8:30am ET-- TEL AVIV, Israel, Aug. 09, 2022 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Sys

Advertisement
Advertisement